News & Analysis on Clinical Trial Services & Contract Research And Development
Unilife has initiated a 24/7 manufacturing cycle at its facility at Lewisberry, Pennsylvania, US after it received marketing clearance for its Unitract 1ml insulin syringes from the US FDA.
Avid Bioservices and Halozyme Therapeutics have expanded their relationship, adding manufacturing agreements and designating the CMO as a preferred supplier.
Contract research organisation (CRO) Ricerca Biosciences has entered into a business development deal with Japan-based Life Science Partner (LSP) to help penetrate the Asian market.